Target intelligence / Profile preview

Chromium ion homeostasis

Molecular classification
Other
01

Overview

Chromium ion homeostasis describes the network of physiological mechanisms controlling the cellular and systemic levels of chromium ions, most notably trivalent chromium (Cr(III)). Chromium is an essential trace element required for normal glucose and lipid metabolism, primarily by potentiating insulin action in tissues via chromodulin-mediated enhancement of insulin receptor activity. The maintenance of appropriate chromium levels is critical for metabolic health, and deficiencies are associated with impaired glucose tolerance and adverse lipid profiles. Supplementation with chromium(III) complexes, such as chromium picolinate, has been explored to improve insulin sensitivity in certain metabolic disorders. While chromium homeostasis is vital for human health, it is a biological state/process and not a classical druggable target such as a receptor, enzyme, or transporter[1][3][5][7].

Other names
Chromium homeostasisChromium(III) homeostasisChromium ion regulation
02

Mechanism of action

Chromium supplementation is thought to enhance insulin receptor signaling, partly via chromodulin (a chromium-binding oligopeptide)[3][5]. - Increased insulin receptor tyrosine kinase activity through chromodulin-chromium complexes[5]. - Activation of AMP-activated protein kinase (AMPK), promoting glucose uptake and energy homeostasis[3].

03

Biological functions

Regulation of glucose metabolismRegulation of lipid metabolismModulation of insulin signalingMaintenance of metabolic processes
04

Disease associations

Type 2 diabetesImpaired glucose toleranceDyslipidemiaPossibly other metabolic disorders
05

Safety considerations

Chromium toxicity at high doses, particularly from hexavalent chromium (Cr(VI)), which is carcinogenic and highly toxic (industrial exposure risk); trivalent chromium (Cr(III)) is generally recognized as safer at nutritional doses[5].Potential oxidative stress and ROS generation at high chromium levels[5].Unclear efficacy and dosing in dietary supplementation.
06

Interacting drugs

Chromium picolinate (dietary supplement)

1 more in the full profile.

07

Biomarkers

Fasting glucoseHemoglobin A1CPlasma or serum chromium levels (for deficiency diagnosis)

Beyond the preview

Go deeper on Chromium ion homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromium ion homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call